Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

Timely and relevant thoracic oncology news brought to you by the only global association dedicated to the multidisciplinary study of lung cancer.

August 2019

August 22, 2019

GLCC and IASLC Form Partnership to Explore Progress in Lung Cancer Treatment

By

Patient Advocacy & Survivorship

Posted: August 22, 2019 The Global Lung Cancer Coalition (GLCC) and the IASLC have formed a partnership to explore the progress that has been made in lung cancer treatment. Through a […]
August 14, 2019

Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel

By

Evolving Standards of Care

Posted: August 14, 2019 Shirish Gadgeel, MBBS, is the Mary Lou Kennedy Research Professor in Thoracic Oncology and a professor in the Division of Hematology/Oncology at the University of Michigan Rogel […]

August 14, 2019

Ireland’s Complex Healthcare System and Its Relation to Innovative Ways for Patients to Access Trials

By

Global Initiatives

By Linda Coate, MD, FRCPI, and Hazel O’Sullivan, MB, Bch, BAO, MRCPI Posted: August 14, 2019 Dr. Linda Coate Dr. Hazel O’Sullivan […]
$Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski$

August 14, 2019

Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski

By

Evolving Standards of Care

Posted: August 14, 2019 Mark A. Socinski, MD, executive medical director of AdventHealth Cancer Institute, spoke with the IASLC Lung Cancer News about his personal recommendations for TKI-refractory disease, especially for […]
August 13, 2019

Making Headway with Lorlatinib

By

Evolving Standards of Care

Posted: August 14, 2019 Lorlatinib, a smallmolecule inhibitor of ALK and ROS1, was granted accelerated U.S. Food and Drug Administration approval in November 2018 for patients with ALK-positive metastatic NSCLC whose […]

August 13, 2019

Korean Lung Cancer Screening Project (K-LUCAS) Led to Launch of New National Lung Cancer Screening Program in Korea

By

Global Initiatives

By Yeol Kim, MD, MPH, PhD, and Choon-Taek Lee, MD, PhD Posted: August 14, 2019 Lung cancer is the leading cause of cancer death worldwide and also in South Korea. Besides […]

August 13, 2019

Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?

By

Evolving Standards of Care

By Christian Rolfo, MD, PhD, MBA, Dr.h.c., and Lori Alexander, MTPW, ELS, MWC Posted: August 14, 2019 Targeted therapy has become the standard of care in patients with advanced NSCLC and […]
August 13, 2019

KEYNOTE-010: Long-Term Outcomes and Results of Retreatment

By

Evolving Standards of Care

By Emily F. Collier, MD; Roy S. Herbst, MD, PhD; and Sarah B. Goldberg, MD, MPH Posted: August 14, 2019 Dr. Emily F. Collier Dr. Roy S. Herbst Dr. Sarah B. […]
August 13, 2019

Lung Cancer Research Highlights from the 2019 ASCO Annual Meeting

By

Meeting News

By Kara Nyberg, PhD Posted: August 14, 2019 The 2019 Annual Meeting of the American Society of Clinical Oncology (ASCO) featured hundreds of lung cancer abstracts encompassing the full spectrum of […]
August 13, 2019

Letter to the Editor: Previously Excluded Patients with Autoimmune Disorders, HIV, and More

By

Systemic, Targeted, & Immune Therapies

Letter to the Editor: Opening Trials to Patients Living with HIVBy Armelle Lavolé, AP-HP Hôpital Tenon, Paris, FrancePosted: August 14, 2019 In response to the article by Dr. Jarushka Naidoo, […]